{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:11:39Z","timestamp":1783545099410,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:00:00Z","timestamp":1236729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:00:00Z","timestamp":1236729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10194-009-0110-x","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T16:25:25Z","timestamp":1236702325000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period"],"prefix":"10.1007","volume":"10","author":[{"given":"Ravi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzeel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basudeb","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"110_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2007.12.028","volume":"1196","author":"J Li","year":"2008","unstructured":"Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22\u201332","journal-title":"Brain Res"},{"key":"110_CR2","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1526-4610.2007.00854.x","volume":"47","author":"S Thalakoti","year":"2007","unstructured":"Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL (2007) Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47:1008\u20131023","journal-title":"Headache"},{"key":"110_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1468-2982.2000.00150.x","volume":"20","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J (2000) Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache. Cephalalgia 20:919\u2013924","journal-title":"Cephalalgia"},{"key":"110_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","volume":"28","author":"H Doods","year":"2007","unstructured":"Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580\u2013587","journal-title":"Trends Pharmacol Sci"},{"key":"110_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1517\/14728222.11.9.1179","volume":"11","author":"L Edvinsson","year":"2007","unstructured":"Edvinsson L (2007) Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists. Expert Opin Ther Targets 11:1179\u20131188","journal-title":"Expert Opin Ther Targets"},{"key":"110_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","volume":"128","author":"E Fusayasu","year":"2007","unstructured":"Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K (2007) Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128:209\u2013214","journal-title":"Pain"},{"key":"110_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","volume":"20","author":"P Sarchielli","year":"2000","unstructured":"Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V (2000) Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20:907\u2013918","journal-title":"Cephalalgia"},{"key":"110_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","volume":"106","author":"G Juhasz","year":"2003","unstructured":"Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461\u2013470","journal-title":"Pain"},{"key":"110_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2005.00836.x","volume":"25","author":"G Juhasz","year":"2005","unstructured":"Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179\u2013183","journal-title":"Cephalalgia"},{"key":"110_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1073\u20131075","journal-title":"N Engl J Med"},{"key":"110_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.clpt.2004.10.001","volume":"77","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005) BIBN4096BS antagonizes human alpha calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202\u2013213","journal-title":"Clin Pharmacol Ther"},{"key":"110_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"110_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1468-29821995.1505384.x","volume":"15","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:384\u2013390","journal-title":"Cephalalgia"},{"key":"110_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1468-2982.2007.01500.x","volume":"27","author":"G Coppola","year":"2007","unstructured":"Coppola G, Pierelli F, Schoenen J (2007) Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia 27:1427\u20131439","journal-title":"Cephalalgia"},{"key":"110_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-3959(00)00232-3","volume":"86","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86:133\u2013138","journal-title":"Pain"},{"key":"110_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1526-4610.2006.00294.x","volume":"46","author":"JL Bellamy","year":"2006","unstructured":"Bellamy JL, Cady RK, Durham PL (2006) Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46:24\u201333","journal-title":"Headache"},{"key":"110_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.20605","volume":"58","author":"JF Tvedskov","year":"2005","unstructured":"Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561\u2013568","journal-title":"Ann Neurol"},{"key":"110_CR18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1212\/WNL.55.9.1335","volume":"55","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J (2000) Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 55:1335\u20131340","journal-title":"Neurology"},{"key":"110_CR19","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1100\/tsw.2002.808","volume":"2","author":"M Ashina","year":"2002","unstructured":"Ashina M (2002) Calcitonin gene-related peptide in tension-type headache. Sci World J 2:1527\u20131531","journal-title":"Sci World J"},{"key":"110_CR20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1212\/01.wnl.0000262045.11646.b1","volume":"68","author":"ME Bigal","year":"2007","unstructured":"Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 68:1851\u20131861","journal-title":"Neurology"},{"key":"110_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0196-9781(91)90147-H","volume":"12","author":"PM Zelissen","year":"1991","unstructured":"Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH (1991) Calcitonin gene-related peptide in human obesity. Peptides 12:861\u2013863","journal-title":"Peptides"},{"key":"110_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1475-097X.1996.tb00557.x","volume":"16","author":"H Lind","year":"1996","unstructured":"Lind H, Brudin L, Lindholm L, Edvinsson L (1996) Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man. Clin Physiol 16:73\u201382","journal-title":"Clin Physiol"},{"issue":"Suppl 1","key":"110_CR23","first-page":"1","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl 1):1\u2013151","journal-title":"Cephalalgia"},{"key":"110_CR24","first-page":"209","volume":"20","author":"M Bartolini","year":"2005","unstructured":"Bartolini M, Baruffaldi R, Paolino I, Silvestrini M (2005) Cerebral blood flow changes in the different phases of migraine. Funct Neurol 20:209\u2013211","journal-title":"Funct Neurol"},{"key":"110_CR25","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/brain\/123.9.1830","volume":"123","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Olesen J (2000) Nitric oxide induced headache in patients with chronic tension-type headache. Brain 123:1830\u20131837","journal-title":"Brain"},{"key":"110_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/sj.bjp.0704842","volume":"137","author":"S Akerman","year":"2002","unstructured":"Akerman S, Williamson DJ, Kaube H, Goadsby PJ (2002) Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 137:62\u201368","journal-title":"Br J Pharmacol"},{"key":"110_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0140-6736(98)01079-4","volume":"353","author":"M Ashina","year":"1999","unstructured":"Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J (1999) Effect of inhibition of nitric oxide synthase on chronic tension- type headache: a randomised crossover trial. Lancet 353:287\u2013289","journal-title":"Lancet"},{"key":"110_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0196-9781(92)90084-G","volume":"13","author":"I Jansen","year":"1992","unstructured":"Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L (1992) Distribution effects of neuropeptide Y, vasoactive intestinal peptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13:527\u2013536","journal-title":"Peptides"},{"key":"110_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/ana.410200409","volume":"20","author":"I Jansen","year":"1986","unstructured":"Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J et al (1986) Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 20:496\u2013501","journal-title":"Ann Neurol"},{"key":"110_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1468-2982.2002.00378.x","volume":"22","author":"D Smith","year":"2002","unstructured":"Smith D, Hill RG, Edvinsson L, Longmore J (2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibers. Cephalalgia 22:424\u2013431","journal-title":"Cephalalgia"},{"key":"110_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1468-2982.2003.00644.x","volume":"24","author":"M Ashina","year":"2004","unstructured":"Ashina M (2004) Neurobiology of chronic tension-type headache. Cephalalgia 24:161\u2013172","journal-title":"Cephalalgia"},{"key":"110_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1526-4610.1997.3709565.x","volume":"37","author":"G Mazzotta","year":"1997","unstructured":"Mazzotta G, Sarchielli P, Gaggioli A, Gallai V (1997) Study of pressure pain and cellular concentration of neurotransmitters related to nociception in episodic tension type headache patients. Headache 37:565\u2013571","journal-title":"Headache"},{"key":"110_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0304-3959(93)90131-8","volume":"52","author":"R Jensen","year":"1993","unstructured":"Jensen R, Rasmussen BK, Pedersen B, Olesen J (1993) Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 52:193\u2013199","journal-title":"Pain"},{"key":"110_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1468-2982.2000.00070.x","volume":"20","author":"L Bendtsen","year":"2000","unstructured":"Bendtsen L (2000) Central sensitization in tension type headache\u2014possible pathophysiological mechanisms. Cephalalgia 20:486\u2013508","journal-title":"Cephalalgia"},{"key":"110_CR35","volume-title":"Mechanism and management of headache","author":"JW Lance","year":"2005","unstructured":"Lance JW, Goadsby PJ (2005) Mechanism and management of headache. Elsevier, Philadelphia"},{"key":"110_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1095\/biolreprod62.4.1033","volume":"62","author":"PR Gangula","year":"2000","unstructured":"Gangula PR, Lanlua P, Wimalawansa S, Supowit S, DiPette D, Yallampalli C (2000) Regulation of calcitonin gene-related peptide expression in dorsal root ganglia of rats by female sex steroid hormones. Biol Reprod 62:1033\u20131039","journal-title":"Biol Reprod"},{"key":"110_CR37","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/bmj.293.6558.1329","volume":"293","author":"JC Stevenson","year":"1986","unstructured":"Stevenson JC, MacDonald DWR, Warren RC (1986) Increased concentration of calcitonin gene-related peptide during normal human pregnancy. Br Med J 293:1329\u20131330","journal-title":"Br Med J"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10194-009-0110-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0110-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:00:12Z","timestamp":1630440012000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1007\/s10194-009-0110-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s10194-009-0110-x","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]},"assertion":[{"value":"22 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}